Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.
China Market Intelligence
Call for Comments: Export Control Law Second Draft July 6th, 2020
Call for Comments: Draft Revised Patent Law July 6th, 2020
Call for Comments: Draft Data Security Law July 6th, 2020